{
    "2021-09-22": [
        [
            {
                "time": "2021-09-22",
                "original_text": "FDA backs Pfizer COVID-19 boosters for seniors and those at high risk",
                "features": {
                    "keywords": [
                        "FDA",
                        "Pfizer",
                        "COVID-19",
                        "boosters",
                        "seniors",
                        "high risk"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-09-23",
                "original_text": "UPDATE 1-Brazil regulator says adolescent death unrelated to Pfizer shot",
                "features": {
                    "keywords": [
                        "Brazil",
                        "regulator",
                        "adolescent",
                        "death",
                        "unrelated",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-24",
                "original_text": "U.S. FDA clears Pfizer COVID-19 booster for older and at-risk Americans",
                "features": {
                    "keywords": [
                        "U.S.",
                        "FDA",
                        "Pfizer",
                        "COVID-19",
                        "booster",
                        "older",
                        "at-risk"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2021-09-25",
                "original_text": "U.S. administers 387.5 mln doses of COVID-19 vaccines - CDC",
                "features": {
                    "keywords": [
                        "U.S.",
                        "administers",
                        "doses",
                        "COVID-19",
                        "vaccines",
                        "CDC"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-26",
                "original_text": "Whether the FDA approves a COVID-19 booster shot or not, Pfizer and Moderna have already made their money",
                "features": {
                    "keywords": [
                        "FDA",
                        "approves",
                        "COVID-19",
                        "booster",
                        "Pfizer",
                        "Moderna"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-27",
                "original_text": "Global tally of COVID-19 cases nears 230 million, as Biden convenes virtual pandemic summit and doubles U.S. purchase of Pfizer vaccine",
                "features": {
                    "keywords": [
                        "global",
                        "tally",
                        "COVID-19",
                        "cases",
                        "Biden",
                        "summit",
                        "Pfizer",
                        "vaccine"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-28",
                "original_text": "Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "collaboration",
                        "U.S.",
                        "vaccine",
                        "donation",
                        "poorest countries"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "international aid"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}